Repligen to Report Third Quarter 2025 Financial Results
Repligen (NASDAQ:RGEN) will report its third quarter 2025 financial results on Tuesday, October 28, 2025. A press release will be issued before the market opens, followed by a conference call at 8:30 a.m. ET to discuss business updates and results for the three- and nine-month periods ended September 30, 2025.
The live call is accessible toll-free at (800) 715-9871 (U.S.) or (646) 307-1963 (international) with no passcode required. A webcast will be available and archived via the company Investor Relations website, and a replay will be posted after the event.
Repligen (NASDAQ:RGEN) rapporterà i suoi risultati del terzo trimestre 2025 il martedì 28 ottobre 2025. Un comunicato stampa sarà emesso prima dell'apertura del mercato, seguito da una conference call alle 8:30 a.m. ET per discutere aggiornamenti aziendali e i risultati per i periodi di tre e nove mesi terminati il 30 settembre 2025.
La chiamata in diretta è accessibile gratuitamente al numero (800) 715-9871 (USA) o al (646) 307-1963 (internazionale) senza bisogno di codice di accesso. Una webcast sarà disponibile e archiviata tramite il sito web Investor Relations dell'azienda, e una replica sarà pubblicata dopo l'evento.
Repligen (NASDAQ:RGEN) reportará sus resultados del tercer trimestre de 2025 el martes 28 de octubre de 2025. Un comunicado de prensa se emitirá antes de la apertura del mercado, seguido de una conferencia telefónica a las 8:30 a.m. ET para discutir actualizaciones comerciales y los resultados de los periodos de tres y nueve meses terminados el 30 de septiembre de 2025.
La llamada en vivo es accesible gratis al número (800) 715-9871 (EE. UU.) o al (646) 307-1963 (internacional) sin necesidad de código de acceso. Habrá un webcast disponible y archivado a través del sitio web de Investor Relations de la empresa, y se publicará una reproducción después del evento.
Repligen (NASDAQ:RGEN)은 2025년 3분기 실적을 2025년 10월 28일 화요일에 발표합니다. 시장 개장 전에 보도자료가 발표되고, 이후 동부 표준시 기준 8:30에 사업 업데이트와 2025년 9월 30일로 끝난 3개월 및 9개월 기간의 실적에 대해 토론하는 컨퍼런스 콜이 있습니다.
라이브 콜은 미국 내 무료전화번호 (800) 715-9871 또는 국제용 (646) 307-1963으로 접속 가능하며 암호가 필요하지 않습니다. 웹캐스트가 회사의 Investor Relations 웹사이트를 통해 제공되고 이벤트 후에 재생본이 게시됩니다.
Repligen (NASDAQ:RGEN) publiera ses résultats du troisième trimestre 2025 le mardi 28 octobre 2025. Un communiqué de presse sera émis avant l’ouverture du marché, suivi d’une conférence téléphonique à 8h30, heure de l’Est pour discuter des mises à jour commerciales et des résultats pour les périodes de trois et neuf mois se terminant le 30 septembre 2025.
L’appel en direct est disponible gratuitement au numéro sans frais (800) 715-9871 (États-Unis) ou au (646) 307-1963 (international) sans code d’accès requis. Un webcast sera disponible et archivé via le site web Investor Relations de l’entreprise, et une rediffusion sera publiée après l’événement.
Repligen (NASDAQ:RGEN) wird seine Ergebnisse des dritten Quartals 2025 am Dienstag, dem 28. Oktober 2025 bekannt geben. Eine Pressemitteilung wird vor Börsenöffnung veröffentlicht, gefolgt von einer Konferenzschaltung um 8:30 Uhr ET, um Unternehmensaktualisierungen und die Ergebnisse für die drei- und neunmonatigen Zeiträume bis zum 30. September 2025 zu besprechen.
Der Live-Anruf ist kostenfrei unter der Nummer (800) 715-9871 (USA) oder (646) 307-1963 (international) erreichbar, ohne Passcode. Ein Webcast wird verfügbar sein und über die Investor Relations-Website des Unternehmens archiviert, und eine Wiederholung wird nach der Veranstaltung veröffentlicht.
Repligen (NASDAQ:RGEN) ستعلن عن نتائجها المالية للربع الثالث من عام 2025 في الثلاثاء 28 أكتوبر 2025. سيصدر بيان صحفي قبل فتح السوق، يليه مؤتمر هاتفي في الساعة 8:30 صباحاً بتوقيت شرق الولايات المتحدة لمناقشة تحديثات الأعمال والنتائج لفترات الثلاثة والتسعة أشهر المنتهية في 30 سبتمبر 2025.
يمكن الوصول إلى المكالمة المباشرة من خلال الرقم المجاني (800) 715-9871 في الولايات المتحدة أو (646) 307-1963 internationally، بدون رمز مرور. سيكون هناك بث مباشر عبر الويب ومتاحة وأرشيف عبر موقع علاقات المستثمرين للشركة، وسيتم نشر إعادة التسجيل بعد الحدث.
Repligen (NASDAQ:RGEN) 将在 2025年第三季度 的财务业绩于 2025年10月28日星期二 公布。新闻稿将在市场开盘前发布，随后在 美国东部时间8:30 召开电话会议，讨论截至 2025年9月30日 的三个月及九个月期间的业务更新与业绩。
现场电话 toll-free 为美国境内 (800) 715-9871，国际为 (646) 307-1963，无需拨入码。将通过公司投资者关系网站提供网络广播并存档，活动结束后还将提供重播。
- None.
- None.
Webcast and Conference Call to Be Held Tuesday, October 28, 2025, at 8:30 a.m. ET
WALTHAM, Mass., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its third quarter 2025 financial results on Tuesday, October 28, 2025. The Company will issue a press release before the market opens and will host a conference call at 8:30 a.m. ET to discuss business updates and financial results for the three- and nine- month reporting periods ended September 30, 2025.
The conference call will be accessible by dialing toll-free (800) 715-9871 for domestic callers and (646) 307-1963 for international callers. No passcode is required for the live call. In addition, a webcast will be accessible via the Investor Relations section of the Company’s website. Both the conference call and webcast will be archived for a period of time following the live event. You can access the replay on the Investor Relations section of Company’s website.
About Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. We are “inspiring advances in bioprocessing” for the customers we serve; primarily biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide. Our focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Our corporate headquarters are located in Waltham, Massachusetts, and the majority of our manufacturing sites are in the U.S., with additional key sites in Estonia, France, Germany, Ireland, the Netherlands and Sweden. For more information about the our company see our website at www.repligen.com, and follow us on LinkedIn.
This press release may contain forward-looking statements within the meaning of the federal securities laws. Investors are cautioned that statements in this press release which are not strictly historical statements including, without limitation, statements identified by words like “believe,” “expect,” “may,” “will,” “should,” “seek,” or “could” and similar expressions, constitute forward-looking statements. Such forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated, including risks discussed from time to time in our filings with the Securities and Exchange Commission. We expressly disclaim any responsibility to update any forward-looking statements, except as required by law.
Repligen Contact:
Jacob Johnson
VP, Investor Relations
(781) 419-0204
investors@repligen.com
FAQ
When will Repligen (RGEN) report Q3 2025 results?
What time is the Repligen (RGEN) Q3 2025 conference call?
How do I join the Repligen (RGEN) conference call on October 28, 2025?
Where can investors watch the Repligen (RGEN) Q3 2025 webcast replay?
Will Repligen (RGEN) provide results for both three- and nine-month periods?
